1. Home
  2. AMTD vs INMB Comparison

AMTD vs INMB Comparison

Compare AMTD & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AMTD IDEA Group each representing six (6)

AMTD

AMTD IDEA Group each representing six (6)

N/A

Current Price

$0.73

Market Cap

71.2M

Sector

N/A

ML Signal

N/A

Logo INmune Bio Inc.

INMB

INmune Bio Inc.

HOLD

Current Price

$2.35

Market Cap

64.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMTD
INMB
Founded
2003
2015
Country
France
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
71.2M
64.7M
IPO Year
2019
2018

Fundamental Metrics

Financial Performance
Metric
AMTD
INMB
Price
$0.73
$2.35
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$5.40
AVG Volume (30 Days)
8.0K
327.1K
Earning Date
04-29-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
11.85
EPS
N/A
N/A
Revenue
N/A
$50,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$1.31
N/A
Revenue Growth
N/A
257.14
52 Week Low
$0.71
$1.09
52 Week High
$1.65
$2.60

Technical Indicators

Market Signals
Indicator
AMTD
INMB
Relative Strength Index (RSI) 45.27 54.39
Support Level $0.71 $2.21
Resistance Level $0.80 $2.55
Average True Range (ATR) 0.04 0.15
MACD -0.00 -0.03
Stochastic Oscillator 41.87 58.27

Price Performance

Historical Comparison
AMTD
INMB

About AMTD AMTD IDEA Group each representing six (6)

AMTD IDEA Group is a diversified institution and digital solutions conglomerate group, connecting companies and investors with world-wide markets. The group operates its businesses in five reportable and operating segments: capital market solutions segment, digital solutions and other services segment, media and entertainment segment, hotel operations, hospitality and VIP services segment, and strategic investment segment. The group generates the majority of its revenue from the strategic investment segment that engages in proprietary investments and management of world-wide investment portfolio (including listed and unlisted equity shares investments and movie rights investments). Its geographic areas are China, Europe, America, and Southeast Asia.

About INMB INmune Bio Inc.

INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.

Share on Social Networks: